About

Next-Generation Cancer Liquid Biopsy Technology

GENEMR is a non-invasive, fast and reliable cancer risk analysis model using cancer specific blood circulating cfRNA biomarker profiles that can detect and differentiate 29 different cancers at very early stages.

Circulating cfRNA transcripts - based liquid biopsy - GENEMR will be able to be used for screening 29 different type of cancer risks at very early stages and for prognosis evaluation after/during cancer treatment.